Biomarkers in Rare Demyelinating Disease of the Central Nervous System

Rare neurological diseases are a heterogeneous group corresponding approximately to 50% of all rare diseases. Neurologists are among the main specialists involved in their diagnostic investigation. At the moment, a consensus guideline on which neurologists may base clinical suspicion is not availabl...

Descripción completa

Detalles Bibliográficos
Autores principales: Boziki, Marina, Sintila, Styliani-Aggeliki, Ioannidis, Panagiotis, Grigoriadis, Nikolaos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665127/
https://www.ncbi.nlm.nih.gov/pubmed/33182495
http://dx.doi.org/10.3390/ijms21218409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665127/
https://www.ncbi.nlm.nih.gov/pubmed/33182495
http://dx.doi.org/10.3390/ijms21218409

Ejemplares similares